Currently, Quest Diagnostics, Inc [DGX] is trading at $172.14, up 0.23%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DGX shares have gain 4.74% over the last week, with a monthly amount glided 12.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on January 06, 2025, when Leerink Partners upgraded its rating to a Outperform and also boosted its price target to $174 from $169. Previously, Morgan Stanley upgraded its rating to Overweight on December 17, 2024, and elevated its price target to $172. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $182 on October 23, 2024. Citigroup upgraded its rating to Buy for this stock on July 10, 2024, and upped its price target to $165. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $135 on this stock.
This stock has fluctuated between a low of $123.30 and a high of $172.64 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $178.14 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $172.14 at the most recent close of the market. An investor can expect a potential return of 3.49% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Trailing Twelve Months sales for Quest Diagnostics, Inc [NYSE:DGX] were 9.87B which represents 14.55% growth. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 170.90 points at the first support level, and at 169.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 172.94, and for the 2nd resistance point, it is at 173.74.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Quest Diagnostics, Inc [NYSE:DGX] is 1.10. Also, the Quick Ratio is 1.02, while the Cash Ratio stands at 0.25. Considering the valuation of this stock, the price to sales ratio is 1.95, the price to book ratio is 2.82 and price to earnings (TTM) ratio is 22.36.
Transactions by insiders
Recent insider trading involved PREVOZNIK MICHAEL E, Officer, that happened on Feb 20 ’25 when 604.0 shares were purchased. Officer, Doherty Catherine T. completed a deal on Feb 20 ’25 to buy 899.0 shares. Meanwhile, Director Gregg Vicky B sold 1250.0 shares on Feb 05 ’25.
